Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. | President, Director | Employee Stock Option (right to buy) | 103K | Jan 3, 2023 | Direct | ||
HTG MOLECULAR DIAGNOSTICS, INC | Director | Stock Option (right to buy) | 8K | Aug 18, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TPST | Tempest Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | President, Director |
HTGMQ | HTG MOLECULAR DIAGNOSTICS, INC | Aug 18, 2022 | 1 | $0 | 4 | Aug 22, 2022 | Director |
HTGMQ | HTG MOLECULAR DIAGNOSTICS, INC | Aug 18, 2022 | 0 | $0 | 3 | Aug 19, 2022 | Director |
TPST | Tempest Therapeutics, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | President, Director |
TPST | Tempest Therapeutics, Inc. | Jan 7, 2022 | 1 | $9.56K | 4 | Jan 11, 2022 | President, Director |
TPST | Tempest Therapeutics, Inc. | Jan 4, 2022 | 1 | $0 | 4 | Jan 6, 2022 | President, Director |
TPST | Millendo Therapeutics, Inc. | Jun 25, 2021 | 5 | $0 | 4 | Jun 29, 2021 | President, Director |
TPST | Millendo Therapeutics, Inc. | Jun 25, 2021 | 0 | $0 | 3 | Jun 29, 2021 | President, Director |